
MOSCOW (Reuters) -A Russian Soyuz MS-28 spacecraft with two Russian cosmonauts and one NASA astronaut on board successfully docked with the International Space Station on Thursday, Russian space agency Roscosmos said.
But the agency later reported that the launch pad at the Baikonur Cosmodrome in Kazakhstan had sustained damage from the launch. It said the damage would be quickly repaired.
The Soyuz 2.1a rocket lifted off from the Baikonur Cosmodrome at 12:28 p.m. Moscow time (0928 GMT).
Late on Thursday, Russian news agencies quoted Roscosmos as saying the launch had taken place without incident, but damage was observed after an inspection of the launch area.
"Damage to a number of elements of the launch pad was detected. An assessment of the state of the launch complex is being conducted now," the agencies quoted Roscosmos as saying.
"All the necessary reserve elements are there to restore it and the damage will be eliminated very soon."
It said the crew was on board the station and in good health.
(Reporting by Anastasia Lyrchikova; Writing by Marina Bobrova; Editing by Andrew Osborn, Ron Popeski and Bill Berkrot)
LATEST POSTS
- 1
Uranus's small moons are dark, red, and water-poor - 2
Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25 - 3
The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles - 4
I asked ChatGPT who would win a Golden Globes. Here's what it got right — and totally wrong. - 5
Figure out How to Get the Most Familiar Drive for Seniors in SUVs
The Most Moving TED Talks You Want to Watch
From Dread to Certainty: Individual Accounts of Strengthening
Golden satellite insulation sparkles during test | Space photo of the day for Dec. 30, 2025
UN estimates over 2,000 Sudanese pregnant women have fled el-Fasher to escape conflict
Courageous Climbing: Trails and Stuff for Outside Lovers
In Antarctica, photos show a remote area teeming with life amid growing risks from climate change
Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item
US FDA declines to approve Corcept's drug for rare hormonal disorder
5 Side interests That Work on Psychological wellness












